GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OTCPK:ZLDPF) » Definitions » 5-Year Yield-on-Cost %

Zealand Pharma A/S (Zealand Pharma A/S) 5-Year Yield-on-Cost % : 0.00 (As of May. 19, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Zealand Pharma A/S 5-Year Yield-on-Cost %?

Zealand Pharma A/S's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Zealand Pharma A/S's 5-Year Yield-on-Cost % or its related term are showing as below:



ZLDPF's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.64
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Zealand Pharma A/S's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Zealand Pharma A/S's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zealand Pharma A/S's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma A/S's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Zealand Pharma A/S's 5-Year Yield-on-Cost % falls into.



Zealand Pharma A/S 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Zealand Pharma A/S is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Zealand Pharma A/S  (OTCPK:ZLDPF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Zealand Pharma A/S 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zealand Pharma A/S (Zealand Pharma A/S) Business Description

Traded in Other Exchanges
Address
Sydmarken 11, Soborg, DNK, DK-2860
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.